Quantcast

NeoImmuneTech partners with Merck on tumor treatment research

A Rockville biopharmaceutical company has entered into a research agreement with a subsidiary of Merck.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*